CIK 0001357874 · Non-accelerated filer<br>Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- operating
- Phone
- 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-02 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −3,605 | 3,605 | ||
| 2024-11-02 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +1,836 | 8,557 | ||
| 2024-11-02 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −1,836 | 1,835 | ||
| 2024-11-02 | Amoroso Michael President and CEO | Option exercise | +9,443 | 31,549 | ||
| 2024-11-02 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units | −9,443 | 9,444 | ||
| 2024-08-22 | SMITH J. JEFFERSON Chief Research Officer | Grant or award · Restricted Stock Units | +48,657 | 48,657 | ||
| 2024-08-22 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +79,725 | 79,725 | ||
| 2024-08-22 | Amoroso Michael President and CEO | Grant or award · Restricted Stock Units | +208,263 | 208,263 | ||
| 2024-08-22 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +44,723 | 44,723 | ||
| 2024-06-10 | Scimeca Dario General Counsel and Secretary | Sale 10b5-1 | −93 | $11.79 | $1K | 6,721 |
| 2024-06-10 | SMITH J. JEFFERSON Chief Research Officer | Sale | −50 | $11.79 | $590 | 68,559 |
| 2024-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +301 | 6,814 | ||
| 2024-06-07 | Scimeca Dario General Counsel and Secretary | Option exercise · Restricted Stock Units 10b5-1 | −301 | 0 | ||
| 2024-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise | +454 | 31,468 | ||
| 2024-06-07 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −454 | 0 | ||
| 2024-06-07 | SMITH J. JEFFERSON Chief Research Officer | Option exercise | +163 | 68,609 | ||
| 2024-06-07 | SMITH J. JEFFERSON Chief Research Officer | Option exercise · Restricted Stock Units | −163 | 0 | ||
| 2024-06-04 | Brown Melinda Director | Grant or award · Restricted Stock Units | +9,826 | 9,826 | ||
| 2024-06-04 | Buehler Kevin Director | Grant or award · Restricted Stock Units | +9,826 | 9,826 | ||
| 2024-06-04 | Frankel Stanley Director | Grant or award · Restricted Stock Units | +9,826 | 9,826 |
Page 8 of 11 · 210 trades